Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-10, Stock:NVS, The news for the past five days is as follows:
2019-07-02: NEWS1: Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx.NEWS2: Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx.NEWS3: Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx.NEWS4: Alnylam Submits MAA in Europe for RNAi Therapeutic Givosiran.NEWS5: Alnylam Submits MAA in Europe for RNAi Therapeutic Givosiran.NEWS6: Alnylam Submits MAA in Europe for RNAi Therapeutic Givosiran.NEWS7: AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label.NEWS8: AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label.NEWS9: Market Morning: Swiss Bans Stocks from EU, Bitcoin Breaks Below $10K, USTR Wants More Tariffs.NEWS10: AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label.NEWS11: Roche's Tecentriq Gets CHMP Recommendation for Breast Cancer.NEWS12: Roche's Tecentriq Gets CHMP Recommendation for Breast Cancer.
2019-07-03: NEWS1: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS2: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS3: Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab.NEWS4: Pre-Market Most Active for Jul 3, 2019 :  SYMC, CGC, NVS, NIO, TSLA, TVIX, OMN, AMD, SAP, ZAYO, TQQQ, QQQ.NEWS5: Pre-Market Most Active for Jul 3, 2019 :  SYMC, CGC, NVS, NIO, TSLA, TVIX, OMN, AMD, SAP, ZAYO, TQQQ, QQQ.
2019-07-05: NEWS1: The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight.
2019-07-08: NEWS1: Novartis' Struggle With Payers Over Zolgensma Is Overblown.NEWS2: Here's Why Coherus BioSciences Is Falling Today.NEWS3: Here's Why Coherus BioSciences Is Falling Today.
2019-07-09: NEWS1: Novo Nordisk Reports Encouraging Data From Hemophilia Studies.NEWS2: Bayer-J&J Announce Positive Xarelto Data in Children with VTE.NEWS3: Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline.NEWS4: Aerie Completes Enrollment Under Rhopressa Study in Japan.NEWS5: The Fundamental Problems of Tilray Stock Are Just Getting Worse.NEWS6: UPDATE 3-Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage.NEWS7: Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage.

Answer: Rise